Literature DB >> 17305273

Transoral robotic surgery: supraglottic partial laryngectomy.

Gregory S Weinstein1, Bert W O'Malley, Wendy Snyder, Neil G Hockstein.   

Abstract

OBJECTIVES: We assessed the feasibility of performing transoral supraglottic partial laryngectomy with robotic instrumentation.
METHODS: Transoral robotic surgery (TORS) was performed on 3 human patients with supraglottic carcinoma in a prospective human trial. The study was approved by our institutional review board and involved the da Vinci Surgical Robot (Intuitive Surgical, Inc, Sunnyvale, California).
RESULTS: All procedures were completed robotically. The median overall operation time to perform the robotic procedure was 120 minutes (range, 1:32:48 to 2:58:18), including 18 minutes (range, 00:6:07 to 00:30:39) for exposure and robotic positioning. There were no intraoperative or postoperative complications or surgical mortality.
CONCLUSIONS: The preliminary results of our series suggest that application of the da Vinci robotic surgical system for TORS to supraglottic partial laryngectomy is technically feasible and relatively safe. Furthermore, TORS provides excellent surgical exposure that allows complete tumor resection. Most importantly, TORS provides an alternative to open approaches and "conventional" transoral supraglottic partial laryngectomy.

Entities:  

Mesh:

Year:  2007        PMID: 17305273     DOI: 10.1177/000348940711600104

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  73 in total

1.  The emergence of endoscopic head and neck surgery.

Authors:  Floyd Christopher Holsinger; Alexander D Sweeney; Kitti Jantharapattana; Ahmed Salem; Randal S Weber; Woong Youn Chung; Carol M Lewis; David G Grant
Journal:  Curr Oncol Rep       Date:  2010-05       Impact factor: 5.075

Review 2.  Current concepts of organ preservation in head and neck cancer.

Authors:  C-J Wang; R Knecht
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-25       Impact factor: 2.503

3.  [Advances in transoral robotic surgery].

Authors:  S Mattheis; B Kansy; P Haßkamp; L Holtmann; S Lang
Journal:  HNO       Date:  2015-11       Impact factor: 1.284

Review 4.  Functional outcomes after supracricoid laryngectomy: what do we not know and what do we need to know?

Authors:  Antonio Schindler; Nicole Pizzorni; Francesco Mozzanica; Marco Fantini; Daniela Ginocchio; Andy Bertolin; Erika Crosetti; Giovanni Succo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-06       Impact factor: 2.503

Review 5.  Robotic surgery for oropharynx cancer: promise, challenges, and future directions.

Authors:  John R de Almeida; Eric M Genden
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

6.  A consensus document on robotic surgery.

Authors:  D M Herron; M Marohn
Journal:  Surg Endosc       Date:  2007-12-28       Impact factor: 4.584

7.  Comparative analysis of resection tools suited for transoral robot-assisted surgery.

Authors:  Thomas K Hoffmann; Patrick J Schuler; Agnes Bankfalvi; Jens Greve; Lukas Heusgen; Stephan Lang; Stefan Mattheis
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-12       Impact factor: 2.503

Review 8.  Minimally Invasive Procedures for Laryngeal Carcinoma: Transoral Endoscopic Laser and Transoral Robotic Surgery.

Authors:  Özgül Topal
Journal:  Turk Arch Otorhinolaryngol       Date:  2017-03-01

9.  Endoscopic laryngo-pharyngeal surgery for superficial laryngo-pharyngeal cancer.

Authors:  Ichiro Tateya; Manabu Muto; Shuko Morita; Shin'ichi Miyamoto; Tomomasa Hayashi; Makiko Funakoshi; Ikuo Aoyama; Hirokazu Higuchi; Shigeru Hirano; Morimasa Kitamura; Seiji Ishikawa; Yo Kishimoto; Mami Morita; Juichi Ito
Journal:  Surg Endosc       Date:  2015-04-28       Impact factor: 4.584

10.  Transoral robotic surgery for oropharyngeal and tongue cancer in the United States.

Authors:  Thomas K Chung; Eben L Rosenthal; J Scott Magnuson; William R Carroll
Journal:  Laryngoscope       Date:  2014-08-05       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.